Harmony Biosciences Holdings (HRMY) Gains from Investment Securities (2019 - 2026)

Harmony Biosciences Holdings has disclosed Gains from Investment Securities across 8 years of filings, most recently posting $1.0 million for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $1.0 million, down 20.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 103.21% YoY), and the FY2025 annual result was $7.9 million, up 9.85% from the prior year.
• Gains from Investment Securities came in at $1.0 million for Q1 2026 at Harmony Biosciences Holdings, up from -$34.1 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $11.6 million in Q4 2022 to a low of -$36.0 million in Q4 2023.
• The 5-year median for Gains from Investment Securities is $467000.0 (2024), against an average of -$1.7 million.
• Peak annual rise in Gains from Investment Securities reached 28729.11% in 2025, while the deepest fall reached 1962.64% in 2025.
• Harmony Biosciences Holdings' Gains from Investment Securities stood at $11.6 million in 2022, then slumped by 410.51% to -$36.0 million in 2023, then jumped by 105.08% to $1.8 million in 2024, then slumped by 1962.64% to -$34.1 million in 2025, then soared by 103.06% to $1.0 million in 2026.
• The last three Gains from Investment Securities figures came in at $1.0 million (Q1 2026), -$34.1 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.